Matches in Wikidata for { <http://www.wikidata.org/entity/Q64697281> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q64697281 description "clinical trial" @default.
- Q64697281 description "ensayu clínicu" @default.
- Q64697281 description "klinik çalışma" @default.
- Q64697281 description "klinisch onderzoek" @default.
- Q64697281 description "клінічне випробування" @default.
- Q64697281 name "A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease" @default.
- Q64697281 type Item @default.
- Q64697281 label "A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease" @default.
- Q64697281 prefLabel "A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease" @default.
- Q64697281 P1132 Q64697281-C358EC1A-3056-4EEE-B21D-977D0713DB8F @default.
- Q64697281 P1476 Q64697281-ABEC58C9-E515-4165-B005-D65E75B7759B @default.
- Q64697281 P17 Q64697281-04BACB94-7C95-4101-8F5D-1DE6A70F0879 @default.
- Q64697281 P17 Q64697281-44B9C2DB-E7F2-4703-A140-D66388363D81 @default.
- Q64697281 P17 Q64697281-E351E406-00A4-454A-87EA-55618AE92DDF @default.
- Q64697281 P17 Q64697281-F2FF37C1-C215-47D9-99C9-B366A92E666B @default.
- Q64697281 P2899 Q64697281-AE06EFD0-7D16-4B3A-9ED8-199E85ED8C86 @default.
- Q64697281 P3098 Q64697281-377C7023-4866-4D20-83E7-D8192D2B1D8E @default.
- Q64697281 P31 Q64697281-E4895969-27E2-494D-AE64-DA75AC3EAF7C @default.
- Q64697281 P4135 Q64697281-CC979DA6-4D98-434C-AAA6-C9C93838D96E @default.
- Q64697281 P580 Q64697281-5F0BC284-564E-4745-B334-D2AA6226DD6F @default.
- Q64697281 P582 Q64697281-BE57BBE6-9921-4A0F-855A-500C96FB9197 @default.
- Q64697281 P6099 Q64697281-30E26C62-82D0-4663-B8B8-CDDF6553CAD4 @default.
- Q64697281 P6153 Q64697281-0664EF3B-4937-4320-B646-59D57A198917 @default.
- Q64697281 P6153 Q64697281-15AE0A12-AE28-4651-922A-39F9D48FECE5 @default.
- Q64697281 P6153 Q64697281-2FCEF1A6-B5CC-4EA0-9C2E-F3C1559070D1 @default.
- Q64697281 P6153 Q64697281-553BE996-36D8-4D31-A1C5-DEFF619BA6E3 @default.
- Q64697281 P6153 Q64697281-7167DC73-9B4B-422F-8F0D-61ACCEECE979 @default.
- Q64697281 P6153 Q64697281-8C706C9D-49D3-4856-A662-6A5EA90520E3 @default.
- Q64697281 P6153 Q64697281-9978034F-6C94-48CA-A9F5-601283E102B9 @default.
- Q64697281 P6153 Q64697281-A2447901-594F-44C4-99BA-0382B213EBFA @default.
- Q64697281 P6153 Q64697281-D7D7CFFF-A4F9-43C0-95B6-EFEF2EA734CE @default.
- Q64697281 P8363 Q64697281-3509D58B-7847-4BCC-8C0D-B450FD148F22 @default.
- Q64697281 P859 Q64697281-2A27AE6F-97D8-4315-B59D-6C9A7A089578 @default.
- Q64697281 P1132 "+209" @default.
- Q64697281 P1476 "Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease" @default.
- Q64697281 P17 Q30 @default.
- Q64697281 P17 Q33 @default.
- Q64697281 P17 Q34 @default.
- Q64697281 P17 Q35 @default.
- Q64697281 P2899 "+50" @default.
- Q64697281 P3098 "NCT00810147" @default.
- Q64697281 P31 Q30612 @default.
- Q64697281 P4135 "+90" @default.
- Q64697281 P580 "2009-02-01T00:00:00Z" @default.
- Q64697281 P582 "2010-06-01T00:00:00Z" @default.
- Q64697281 P6099 Q42824440 @default.
- Q64697281 P6153 Q1472663 @default.
- Q64697281 P6153 Q149990 @default.
- Q64697281 P6153 Q30269704 @default.
- Q64697281 P6153 Q30269718 @default.
- Q64697281 P6153 Q309331 @default.
- Q64697281 P6153 Q43896939 @default.
- Q64697281 P6153 Q49088 @default.
- Q64697281 P6153 Q5002619 @default.
- Q64697281 P6153 Q61931487 @default.
- Q64697281 P8363 Q78089383 @default.
- Q64697281 P859 Q266423 @default.